Ascendis Pharma Receives Positive CHMP Opinion for TransCon™ PTH (palopegteriparatide) for Adults with Chronic Hypoparathyroidism

September 24, 2023

https://investors.ascendispharma.com/news-releases/news-release-details/ascendis-pharma-receives-positive-chmp-opinion-transcontm-pth

Back to News